Trinity Biotech plc (TRIB)
NASDAQ: TRIB · IEX Real-Time Price · USD
-0.240 (-7.84%)
At close: Jul 16, 2024, 4:00 PM
+0.140 (4.96%)
After-hours: Jul 16, 2024, 5:20 PM EDT

Company Description

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland.

The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes.

It also provides laboratory-testing services for Sjogren’s syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, systemic sclerosis, and other laboratory-testing services for autoimmune disorders.

The company develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia.

It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners.

Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.

Trinity Biotech plc
Trinity Biotech logo
Country Ireland
Founded 1992
Industry Medical Devices
Sector Healthcare
Employees 380
CEO John Gillard

Contact Details

Ida Business Park, Bray, Co Wicklow, Ireland
Dublin Ireland, L2 18
Phone 01135312955111

Stock Details

Ticker Symbol TRIB
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000888721
CUSIP Number 896438306
ISIN Number US8964385046
SIC Code 2835

Key Executives

Name Position
John Gillard President, Chief Executive Officer, Company Secretary and Director
Ronan O'Caoimh Founder and Director
Dr. James Walsh Ph.D. Executive Director of Business Development and Executive Director
Des Fitzgerald Interim Chief Financial Officer
Simon Dunne Chief Accounting Officer
Dr. Gary Keating Ph.D. Chief Technology Officer
Eibhlin Kelly Chief Information Officer
Colm Molloy Group Director of Human Resources and Culture

Latest SEC Filings

Date Type Title
Jul 12, 2024 6-K Report of foreign issuer
Jul 12, 2024 424B5 Filing
Jul 12, 2024 20-F/A Filing
Jul 11, 2024 6-K Report of foreign issuer
Jun 28, 2024 EFFECT Notice of Effectiveness
Jun 28, 2024 F-3/A Filing
Jun 21, 2024 F-3 Filing
May 28, 2024 6-K Report of foreign issuer
May 16, 2024 6-K Report of foreign issuer
May 7, 2024 EFFECT Notice of Effectiveness